Cargando…
Allosteric Site Inhibitor Disrupting Auto-Processing of Malarial Cysteine Proteases
Falcipains are major haemoglobinases of Plasmodium falciparum required for parasite growth and development. They consist of pro- and mature domains that interact via ‘hot-spot’ interactions and maintain the structural integrity of enzyme in zymogen state. Upon sensing the acidic environment, these i...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212536/ https://www.ncbi.nlm.nih.gov/pubmed/30385827 http://dx.doi.org/10.1038/s41598-018-34564-8 |
_version_ | 1783367560209629184 |
---|---|
author | Pant, A. Kumar, R. Wani, N. A. Verma, S. Sharma, R. Pande, V. Saxena, A. K. Dixit, R. Rai, R. Pandey, K. C. |
author_facet | Pant, A. Kumar, R. Wani, N. A. Verma, S. Sharma, R. Pande, V. Saxena, A. K. Dixit, R. Rai, R. Pandey, K. C. |
author_sort | Pant, A. |
collection | PubMed |
description | Falcipains are major haemoglobinases of Plasmodium falciparum required for parasite growth and development. They consist of pro- and mature domains that interact via ‘hot-spot’ interactions and maintain the structural integrity of enzyme in zymogen state. Upon sensing the acidic environment, these interactions dissociate and active enzyme is released. For inhibiting falcipains, several active site inhibitors exist, however, compounds that target via allosteric mechanism remains uncharacterized. Therefore, we designed and synthesized six azapeptide compounds, among which, NA-01 & NA-03 arrested parasite growth by specifically blocking the auto-processing of falcipains. Inhibitors showed high affinity for enzymes in presence of the prodomain without affecting the secondary structure. Binding of NA-03 at the interface induced rigidity in the prodomain preventing structural reorganization. We further reported a histidine-dependent activation of falcipain. Collectively, for the first time we provide a framework for blocking the allosteric site of crucial haemoglobinases of the human malaria parasite. Targeting the allosteric site could provide high selectivity and less vulnerable to drug resistance. |
format | Online Article Text |
id | pubmed-6212536 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-62125362018-11-06 Allosteric Site Inhibitor Disrupting Auto-Processing of Malarial Cysteine Proteases Pant, A. Kumar, R. Wani, N. A. Verma, S. Sharma, R. Pande, V. Saxena, A. K. Dixit, R. Rai, R. Pandey, K. C. Sci Rep Article Falcipains are major haemoglobinases of Plasmodium falciparum required for parasite growth and development. They consist of pro- and mature domains that interact via ‘hot-spot’ interactions and maintain the structural integrity of enzyme in zymogen state. Upon sensing the acidic environment, these interactions dissociate and active enzyme is released. For inhibiting falcipains, several active site inhibitors exist, however, compounds that target via allosteric mechanism remains uncharacterized. Therefore, we designed and synthesized six azapeptide compounds, among which, NA-01 & NA-03 arrested parasite growth by specifically blocking the auto-processing of falcipains. Inhibitors showed high affinity for enzymes in presence of the prodomain without affecting the secondary structure. Binding of NA-03 at the interface induced rigidity in the prodomain preventing structural reorganization. We further reported a histidine-dependent activation of falcipain. Collectively, for the first time we provide a framework for blocking the allosteric site of crucial haemoglobinases of the human malaria parasite. Targeting the allosteric site could provide high selectivity and less vulnerable to drug resistance. Nature Publishing Group UK 2018-11-01 /pmc/articles/PMC6212536/ /pubmed/30385827 http://dx.doi.org/10.1038/s41598-018-34564-8 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Pant, A. Kumar, R. Wani, N. A. Verma, S. Sharma, R. Pande, V. Saxena, A. K. Dixit, R. Rai, R. Pandey, K. C. Allosteric Site Inhibitor Disrupting Auto-Processing of Malarial Cysteine Proteases |
title | Allosteric Site Inhibitor Disrupting Auto-Processing of Malarial Cysteine Proteases |
title_full | Allosteric Site Inhibitor Disrupting Auto-Processing of Malarial Cysteine Proteases |
title_fullStr | Allosteric Site Inhibitor Disrupting Auto-Processing of Malarial Cysteine Proteases |
title_full_unstemmed | Allosteric Site Inhibitor Disrupting Auto-Processing of Malarial Cysteine Proteases |
title_short | Allosteric Site Inhibitor Disrupting Auto-Processing of Malarial Cysteine Proteases |
title_sort | allosteric site inhibitor disrupting auto-processing of malarial cysteine proteases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212536/ https://www.ncbi.nlm.nih.gov/pubmed/30385827 http://dx.doi.org/10.1038/s41598-018-34564-8 |
work_keys_str_mv | AT panta allostericsiteinhibitordisruptingautoprocessingofmalarialcysteineproteases AT kumarr allostericsiteinhibitordisruptingautoprocessingofmalarialcysteineproteases AT wanina allostericsiteinhibitordisruptingautoprocessingofmalarialcysteineproteases AT vermas allostericsiteinhibitordisruptingautoprocessingofmalarialcysteineproteases AT sharmar allostericsiteinhibitordisruptingautoprocessingofmalarialcysteineproteases AT pandev allostericsiteinhibitordisruptingautoprocessingofmalarialcysteineproteases AT saxenaak allostericsiteinhibitordisruptingautoprocessingofmalarialcysteineproteases AT dixitr allostericsiteinhibitordisruptingautoprocessingofmalarialcysteineproteases AT rair allostericsiteinhibitordisruptingautoprocessingofmalarialcysteineproteases AT pandeykc allostericsiteinhibitordisruptingautoprocessingofmalarialcysteineproteases |